INHIBITORS OF L1 AND ADAM10 FOR THE TREATMENT OF CARCINOMAS

摘要

Described is a pharmaceutical composition comprising a compound (s) interfering with the biological activity of L1 and/or ADAM10 or their expression. Also described is the use of said compound (s) for the prevention/treatment of carcinomas like ovarian and endometrial carcinoma. Finally, the diagnosis of highly malignant forms of carcinomas which is based on the determination of the activity/expression of L1 and/or ADAM10 is described.